CACI International

CACI · NYSE

$607.75−$8.73 (−1.42%)TodayMarket closed · Oct 20, 7:34 PM ET

Prev close $616.48

CACI analyst rating

BuyConsensus of 12 analysts over the last 12 months. 75% rate it a buy.

Strong buy0
Buy9
Hold2
Underperform1
Sell0

12-month price target · 18 analysts

Average $741.94 (+22.1% upside)

Low: $653.58
Now: $607.75
High: $936.60

Upgrades and downgrades

The latest rating actions, newest first

CACI analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Macquarie	Oct 16, 2026	Initiates	Outperform	$780.00	0%
Citigroup	Oct 7, 2026	Maintains	Neutral	$648.00 → $689.00	27%
BNP Paribas	Oct 6, 2026	Downgrade	Neutral → Underperform	$675.00 → $540.00	68%
Citigroup	Aug 11, 2026	Maintains	Neutral	$519.00 → $648.00	27%
UBS	Aug 7, 2026	Maintains	Buy	$598.00 → $804.00	49%
JP Morgan	Aug 7, 2026	Maintains	Overweight	$645.00 → $715.00	63%
TD Cowen	Jul 7, 2026	Maintains	Buy	$625.00 → $550.00	63%
Jefferies	Jul 1, 2026	Maintains	Hold	$550.00 → $510.00	55%
Citigroup	Jul 1, 2026	Maintains	Neutral	$555.00 → $519.00	27%
JP Morgan	Jun 15, 2026	Maintains	Overweight	$700.00 → $645.00	63%

The case for and against

Updated Apr 10, 2026

Bull case

CACI International's focused bidding strategy has resulted in a strong backlog, supporting a projected sustainable growth rate of mid-single digits and improved margins. The company demonstrated robust free cash flow generation, reporting $138 million in FQ1, contributing to a year-to-date total of $281 million, which bolsters its financial stability. Additionally, CACI raised its fiscal year 2026 revenue guidance to a range of $9.3 billion to $9.5 billion, reflecting an expected year-over-year growth of 8-10%, indicating strong operational performance against favorable industry dynamics.

Bear case

CACI International Inc. reported FQ2 revenues of $2.20 billion, which fell short of analysts' expectations, indicating weakened performance in a challenging contracting environment. The company's booked contract awards totaled only $1.4 billion, yielding a low book-to-bill ratio of 0.6x and a declining funded backlog of $4.4 billion, which reflects a notable reduction in coverage compared to prior years. Additionally, potential headwinds such as federal budget disruptions, staffing challenges, and competitive pricing pressure further compound the negative outlook for CACI's growth and margins moving forward.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.